The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 18,001–18,100 of 31,469
Association between IL-15 and obesity: IL-15 as a potential regulator of fat mass
Nielsen, A. R., Højman, P., Erikstrup, C., Plomgaard, P., Mounier, R., Mortensen, O. H., Taudorf, S., Krogh‐Madsen, R., Lindegaard, B., Petersen, W., et al. (2008) · Cited by 15
Nsiah-Kumi, P. A., Beals, J. L., Lasley, S., Whiting, M. H. S., Brushbreaker, C., Erickson, J. M., Qiu, F., Yu, F., Canaris, G. J., & Larsen, J. L. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30714-8 · Cited by 15
Olver, T. D., Hazell, T. J., Hamilton, C. D., Shoemaker, J. K., & Lemon, P. W. R. (2012) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h11-148 · Cited by 15
Mori, Y., Itoh, Y., Komiya, H., & Tajima, N. (2005) · Endocrine · doi:10.1385/endo:28:2:157 · Cited by 15
Pravdova, E., Macho, L., Hlaváčová, N., et al. (2007) · PubMed · Cited by 15
Marcinkowska, M., Lewandowski, K. C., Lewiñski, A., Bieńkiewicz, M., Basińska-Lewandowska, M., Salata, I., & Randeva, H. S. (2007) · PubMed · Cited by 15
Assar, M. E., Fernández, A., Sánchez‐Ferrer, A., Angulo, J., & Rodríguez‐Mañas, L. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.012 · Cited by 15
Mohteshamzadeh, M., WILKINSON, R., & THOMAS, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.026 · Cited by 15
Clinical and biochemical manifestations of syndrome X in obese children
Papadopoulou‐Alataki, E., Papadopoulou‐Legbelou, K., Doukas, L., Karatzidou, K., Pavlitou, A., & Pagkalos, E. M. (2004) · European Journal of Pediatrics · doi:10.1007/s00431-004-1483-0 · Cited by 15
Shimomura, T., Anan, F., Umeno, Y., et al. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02062.x · Cited by 15
Kanauchi, M., Akai, Y., & Hashimoto, T. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064072 · Cited by 15
Prediabetes in Rural and Urban Children in 3 States in Mexico
Aradillas-García, C., Malacara, J. M., Garay‐Sevilla, M. E., Guízar, J. M., Camacho, N., Mendoza, E. D. L. C., Quemada, L., & Sierra, J. F. H. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.05847.x · Cited by 15
Trends, associations and predictions of insulin resistance in prepubertal children (EarlyBird 29)
Gardner, D. S.-L., Metcalf, B. S., Hosking, J., Jeffery, A., Voss, L. D., & Wilkin, T. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00380.x · Cited by 15
Short-term oral oleoyl-estrone treatment increases plasma cholesterol turnover in the rat
Cabot, C., Salas, A., Ferrer‐Lorente, R., et al. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802898 · Cited by 15
Gaudio, G. V., Guasti, L., Schizzarotto, A., Simoni, C., Crespi, C., Cimpanelli, M., Klersy, C., Grandi, A. M., Riganti, G., & Venco, A. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000157442.95354.0d · Cited by 15
Hattori, A., Uemura, K., Miura, H., UEDA, M., Tamaya, N., Iwata, F., Muraguchi, M., Ohmoto, Y., & Iguchi, A. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.615 · Cited by 15
Herlihy, O. M., Barrow, B. A., Grant, P. J., & Lévy, J. (2002) · Diabetologia · doi:10.1007/s00125-002-0795-8 · Cited by 15
Rettenbacher, M. A., Hummer, M., Hofer, A., Baumgartner, S., Ebenbichler, C. F., Edlinger, M., Kemmler, G., Lechleitner, M., & Fleischhacker, W. W. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106069467 · Cited by 14
Tokudome, M., Nagasaki, M., Shimaoka, K., & Sato, Y. (2004) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2004.00241.x · Cited by 15
Gender-related response of lipid metabolism to dietary fatty acids in the hamster
Morise, A., Mourot, J., Boué, C., Combe, N., Amsler, G., Gripois, D., Quignard‐Boulangé, A., Yvan‐Charvet, L., Fénart, É., Weill, P., et al. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051721 · Cited by 17
Candela, J. M., Nadal, J., Ortiz, J. R., Domínguez, C. C., Martín, A. G., & Pérez, M. (2006) · Atención Primaria · doi:10.1157/13090435 · Cited by 13
Lim, S.-C., Tan, B., Chew, S., & Tan, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802140 · Cited by 14
Tai, E. S., Ho, S.-C., Fok, A. C. K., & Tan, C. E. (1999) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v28n3p445 · Cited by 15
Witchel, S. F., Trivedi, R. N., & Kammerer, C. M. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00506-5 · Cited by 15
Berezin, A. Е., Kremzer, A. A., Berezina, T. A., et al. (2016) · Data in Brief · doi:10.1016/j.dib.2016.06.015 · Cited by 15
Pontes, K. S. D. S., Guedes, M. R., Souza, P. G. D., Neves, M. F. T., & Klein, M. R. S. T. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.05.005 · Cited by 16
Madjd, A., Taylor, M. A., Delavari, A., Malekzadeh, R., Macdonald, I. A., & Farshchi, H. R. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-019-0495-9 · Cited by 13
“Insulin resistance was evaluated by HOMA-IR, which was calculated by using the following formula [21]:”
MethodElsabaawy, M., Torkey, M., Magdy, M., & Naguib, M. (2025) · European Journal of Medical Research · doi:10.1186/s40001-025-03151-9 · Cited by 14
“…used: • Power: 80% (β = 0.20) • Significance level: 5% (α = 0.05, two-sided) • Effect size: Cohen’s f = 0.25 (moderate effect) • Number of groups: 3 (Subtypes 1, 2, and 3) • Expected variability: Standard deviation of ASCVD risk score ≈ 0.10, based on preliminary data from MASLD cohorts [8, 9].”
InfluentialTindle, H. A., Duncan, M. S., Liu, S., Kuller, L. H., Fugate Woods, N., Rapp, S. R., Kroenke, C. H., Coday, M., Loucks, E. B., Lamonte, M. J., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12584 · Cited by 20
Tripathy, D., Lindholm, E., Isomaa, B., Saloranta, C., Tuomi, T., & Groop, L. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00113.2003 · Cited by 20
Ashour, A. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1416238 · Cited by 14
Mansour, M. F., Behairy, A., Mostafa, M., Khamis, T., Alsemeh, A. E., Ahmed, N. M. Q., & El-Emam, M. M. A. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117337 · Cited by 14
Lin, H., Ding, Y., Jia, X., Gu, X., Wang, S., Li, M., Xu, Y. H., Xu, M., Mu, Y., Chen, L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102212 · Cited by 16
Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism
Fan, Y., Lyu, L., Vazquez-Uribe, R., Zhang, W., Bongers, M., Koulouktsis, A., Yang, M., Sereikaité, V., Arora, T., Stankevič, E., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02064-x · Cited by 15
Moriyama, K. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i29.108380 · Cited by 26
Fernández‐Rodríguez, A., Berenguer, J., Jiménez‐Sousa, M. Á., et al. (2015) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2015.10.006 · Cited by 14
Mansoori, A., Sotoudeh, G., Djalali, M., Eshraghian, M., Keramatipour, M., Nasli‐Esfahani, E., Shidfar, F., Alvandi, E., Toupchian, O., & Koohdani, F. (2015) · Lifestyle Genomics · doi:10.1159/000442792 · Cited by 14
Baronio, F., Mazzanti, L., Girtler, Y., Tamburrino, F., Fazzi, A., Lupi, F., Longhi, S., & Radetti, G. (2016) · Hormone Research in Paediatrics · doi:10.1159/000448841 · Cited by 14
Genetic analysis of single-minded 1 gene in early-onset severely obese children and adolescents
Staníková, D., Bužga, M., Krumpolec, P., Škopková, M., Sůrová, M., Ukropcová, B., Tichá, Ľ., Petrášová, M., Gabcova, D., Hučková, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177222 · Cited by 14
Lu, M., Fang, W.-C., Li, W.-C., Yeh, W.-C., Shieh, Y., & Chen, J. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197195 · Cited by 14
Ożegowska, K., Korman, M., Szmyt, A., & Pawelczyk, L. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249291 · Cited by 18
de Carvalho, C. S., Silva, T. H., André, J. C. S., de Barros, L. A. S., Ferreira, A. A., Murad, L. B., & Peres, W. A. F. (2020) · Nutrition in Clinical Practice · doi:10.1002/ncp.10624 · Cited by 13
Rice bran modulates renal disease risk factors in animals submitted to high sugar-fat diet
Siqueira, J. S., Francisqueti‐Ferron, F. V., Garcia, J. L., Silva, C. C. V. D. A., Costa, M. R., Nakandakare-Maia, E. T., Moreto, F., Ferreira, A. L. A., Minatel, I. O., Ferron, A. J. T., et al. (2021) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2020-0169 · Cited by 14
Multi-Omics Data Analysis Uncovers Molecular Networks and Gene Regulators for Metabolic Biomarkers
Jung, S. Y. (2021) · Biomolecules · doi:10.3390/biom11030406 · Cited by 13
Guo, X., Zhu, Y., Li, X., Lu, Z., Cao, Z., Yi, X., & Zhu, X. (2021) · Psychogeriatrics · doi:10.1111/psyg.12675 · Cited by 14
Yaghooti, H., Ghanavati, F., Seyedian, S. S., et al. (2021) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-021-00485-y · Cited by 14
Zhou, X. P., Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9372 · Cited by 14
de Lima, T. R., Sui, X., de Lima, L. R. A., & Silva, D. A. S. (2021) · World Journal of Pediatrics · doi:10.1007/s12519-021-00460-x · Cited by 16
Christen, T., de Mutsert, R., Lamb, H. J., van Dijk, K. W., le Cessie, S., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2021) · Peptides · doi:10.1016/j.peptides.2021.170664 · Cited by 14
Ramos, L. V., da Costa, T. H. M., & Arruda, S. F. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108881 · Cited by 14
Swauger, S. E., Hornung, L. N., Elder, D. A., Balamurugan, A. N., Vitale, D. S., Lin, T. K., Nathan, J. D., & Abu‐El‐Haija, M. A. (2022) · Diabetes Care · doi:10.2337/dc21-1222 · Cited by 14
Tutar, D., Çintesun, F. N. İ., Günenç, O., & Çetinkaya, Ç. D. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2036956 · Cited by 14
Mazri, F. H., Manaf, Z. A., Shahar, S., Ludin, A. F. M., & Basir, S. M. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084469 · Cited by 18
Vitamin D insufficiency, excessive weight gain, and insulin resistance during pregnancy
Rodrigues, C. Z., Cardoso, M. A., Maruyama, J. M., Neves, P. A. R., Qi, L., & Lourenço, B. H. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.05.009 · Cited by 14
Winn, M., Karra, P., Haaland, B. A., Doherty, J. A., Summers, S. A., Litchman, M. L., Gunter, M. J., Playdon, M. C., & Hardikar, S. S. (2022) · Cancer Medicine · doi:10.1002/cam4.4912 · Cited by 14
Kumar, P., Ram, H., Kala, C., Kashyap, P., Singh, G., Agnihotri, C., Singh, B. P., Kumar, A., & Panwar, A. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2103029 · Cited by 14
Controlled attenuation parameter accurately detects liver steatosis in people with HIV
Duarte, M., Tien, P. C., Ma, Y., Noworolski, S. M., Korn, N. J., & Price, J. C. (2022) · AIDS · doi:10.1097/qad.0000000000003351 · Cited by 14
Distress response in granulosa cells of women affected by PCOS with or without insulin resistance
Cozzolino, M., Herraiz, S., Çakıroğlu, Y., García-Velasco, J. A., Tıraş, B., Pacheco, A., Rabadán, S., Kohls, G., Barrio, A., Pellicer, A., et al. (2022) · Endocrine · doi:10.1007/s12020-022-03192-8 · Cited by 14
Gil‐Cardoso, K., Bas-Prior, J. M. D., Caimari, A., Lama, C., Torres, S., Mantecón, L., & Infante, C. (2022) · Nutrients · doi:10.3390/nu14194028 · Cited by 16
Yang, C., Liu, X., Dang, Y., Li, J., Jing, J., Tian, D., Qiu, J., Zhang, J., Yan, N., Liu, X., et al. (2022) · International Journal of Public Health · doi:10.3389/ijph.2022.1604986 · Cited by 15
Navarro, J. A., Díaz, C., Decara, J. M., Vera, D. M., López-Gambero, A. J., Suárez, J., Pavón, F. J., Serrano, A., Vargas, A., Gavito, A., et al. (2022) · Nutrients · doi:10.3390/nu14194094 · Cited by 15
Simon, A. B., Brener, A., Segev‐Becker, A., Yackobovitch‐Gavan, M., Uretzky, A., Davidov, A. S., Alaev, A., Oren, A., Eyal, O., Weintrob, N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1022752 · Cited by 15
Sepúlveda-Fragoso, V., Alexandre‐Santos, B., Barreto-Reis, E., Fernandes, T., de Oliveira, E. M., Cavalcanti, S. N. V., Atella, G. C., Miranda‐Alves, L., Vázquez‐Carrera, M., da Nóbrega, A. C. L., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121136 · Cited by 13
Sasani, N., Kazemi, A., Babajafari, S., Amiri-Ardekani, E., Rezaiyan, M., Barati‐Boldaji, R., Mazloomi, S., Clark, C., & Ashrafi-Dehkordi, E. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3123 · Cited by 13
Berman, Y. E., Doherty, D. A., Mori, T. A., Beilin, L. J., Ayonrinde, O. T., Adams, L. A., Huang, R., Olynyk, J. K., Keelan, J. A., Newnham, J. P., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192215244 · Cited by 14
Kempf, E., Landgraf, K., Vogel, T., Spielau, U., Stein, R., Raschpichler, M., Kratzsch, J., Kieß, W., Staník, J., & Körner, A. (2022) · Adipocyte · doi:10.1080/21623945.2022.2148886 · Cited by 14
Yin, J., Freedman, N. D., Liu, Y., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02042-8 · Cited by 14
Epigenetics of type 2 diabetes and diabetes-related outcomes in the Strong Heart Study
Domingo‐Relloso, A., Gribble, M. O., Riffo‐Campos, Á. L., Haack, K., Cole, S. A., Téllez-Plaza, M., Umans, J. G., Fretts, A. M., Zhang, Y., Fallin, M. D., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01392-7 · Cited by 14
Sasaki, G. Y., Vodovotz, Y., Yu, Z., & Bruno, R. S. (2022) · Antioxidants · doi:10.3390/antiox11122490 · Cited by 14
Stein, R., Koutny, F., Riedel, J., Dörr, N., Meyer, K., Colombo, M., Vogel, M., Anderwald, C. H., Blüher, M., Kieß, W., et al. (2023) · Metabolites · doi:10.3390/metabo13010100 · Cited by 17
Castillo, P., Pomar, C. A., Palou, A., Palou, M., & Picó, C. (2023) · Nutrients · doi:10.3390/nu15030570 · Cited by 16
Brain-derived neurotrophic factor associated with kidney function
Hsu, C.-Y., Sheu, W. H., & Lee, I. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00991-5 · Cited by 14
Calcaterra, V., Bernardelli, G., Malacarne, M., Vandoni, M., Mannarino, S., Pellino, V. C., Larizza, C., Pagani, M., Zuccotti, G., & Lucini, D. (2023) · Nutrients · doi:10.3390/nu15041054 · Cited by 14
Li, Y., Wang, Y., Liu, H., Zhang, S., & Zhang, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1117996 · Cited by 14
Sarajlic, P., Vigor, C., Avignon, A., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.03.007 · Cited by 14
Increased GH/IGF-I Axis Activity Relates to Lower Hepatic Lipids and Phosphor Metabolism
Fellinger, P., Beiglböck, H., Semmler, G., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad206 · Cited by 14
Huang, X., Zhao, Y., Liu, T., Wu, D., Shu, J., Yue, W., Zhang, W., & Liu, S. (2023) · Diabetes · doi:10.2337/db22-1048 · Cited by 14
Cyclo(His-Pro): A further step in the management of steatohepatitis
Masi, A. D., Li, X., Lee, D., Jeon, J., Wang, Q., Baek, S., Park, O., Mottis, A., Strotjohann, K., Rapin, A., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100815 · Cited by 14
Yun, N., Nah, J., Lee, M. N., Wu, D., & Pae, M. (2023) · Nutrients · doi:10.3390/nu15112617 · Cited by 14
Antoniak-Pietrynczak, K., Zorena, K., Jaskulak, M., Hansdorfer-Korzon, R., & Koziński, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210338 · Cited by 14
Prediction of Diabetic Kidney Disease in Newly Diagnosed Type 2 Diabetes Mellitus
Mu, X., Wu, A., Hu, H., Zhou, H., & Yang, M. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s417300 · Cited by 14
Shadiow, J., Miranda, E. R., Perkins, R. K., Mazo, C. E., Lin, Z., Lewis, K. N., Mey, J. T., Solomon, T. P. J., & Haus, J. M. (2023) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00662.2022 · Cited by 11
Li, D., Dun, Y., Qi, D., Ripley-Gonzalez, J. W., Dong, J., Zhou, N., Qiu, L., Zhang, J., Zeng, T., You, B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-40373-5 · Cited by 16
Choroidal vascular changes in non-alcoholic fatty liver disease
Avcı, E., & Küçüködük, A. (2023) · Endokrynologia Polska · doi:10.5603/ep.95686 · Cited by 15
Galantamine improves glycemic control and diabetic nephropathy in Leprdb/db mice
Meng, Q., Ma, J., Suo, L., Pruekprasert, N., Chakrapani, P., & Cooney, R. N. (2023) · Scientific Reports · doi:10.1038/s41598-023-42665-2 · Cited by 15
Ren, X., Zhang, F., Zhang, M., Fang, Y., Chen, Z., & Huan, M. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250167 · Cited by 15
Khalili-Moghadam, S., Hedayati, M., Golzarand, M., & Mirmiran, P. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1241844 · Cited by 14
Werida, R. H., Ramzy, A., Ebrahim, Y. N., & Helmy, M. W. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01511-2 · Cited by 18
Gan, J., Chen, J., Ma, R.-L., Deng, Y., Ding, X.-S., Zhu, S., & Sun, A. (2023) · International Journal of Endocrinology · doi:10.1155/2023/4288004 · Cited by 14
Font, M. M., Busquets-Cortés, C., Ramírez‐Manent, J. I., Tomás-Gil, P., Paublini, H., & López‐González, Á. A. (2023) · Nutrients · doi:10.3390/nu15245122 · Cited by 14
Liu, W., Lian, L., Zhang, H., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad749 · Cited by 14
Hieronimus, B., Medici, V., Lee, V., Nuñez, M. V., Sigala, D. M., Bremer, A. A., Cox, C. L., Keim, N. L., Schwarz, J., Pacini, G., et al. (2024) · Nutrients · doi:10.3390/nu16010151 · Cited by 16
Köktürk, U., Önalan, O., Somuncu, M. U., Akgül, Ö., Uygur, B., & Püşüroğlu, H. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.12.025 · Cited by 15
Han, W., Zhang, M., Wang, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1279978 · Cited by 14
Liu, D., Zhang, Y., Wu, Q., Han, R., Cheng, D., Wu, L., Guo, J., Yu, X., Ge, W., Ni, J., et al. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13549 · Cited by 18
Georgoulis, M., Damigou, E., Derdelakou, E., Kosti, R. I., Chrysohoou, C. A., Barkas, F., Kravvariti, E., Tsioufis, C. P., Pitsavos, C. S., Liberopoulos, E. N., et al. (2024) · European Journal of Clinical Nutrition · doi:10.1038/s41430-024-01440-w · Cited by 14
Factors associated with body weight gain and insulin-resistance: a longitudinal study
Buscemi, C., Randazzo, C., Barile, A. M., Bo, S., Ponzo, V., Caldarella, R., Malavazos, A. E., Caruso, R., Colombrita, P., Lombardo, M., et al. (2024) · Nutrition and Diabetes · doi:10.1038/s41387-024-00283-5 · Cited by 14
Rizk, F. H., Saadany, A. A. E., Elshamy, A. M., Ellatif, R. A. A., El-Guindy, D. M., Helal, D. S., Hamama, M. G., El-Sharnouby, J. A., Ghafar, M. T. A., & Faheem, H. (2024) · The Journal of Physiology · doi:10.1113/jp285793 · Cited by 15
Shift work and non-alcoholic fatty liver disease in young, healthy workers
Lee, Y., & Lee, W. (2024) · Scientific Reports · doi:10.1038/s41598-024-70538-9 · Cited by 16
Diabetes and Uterine Fibroid Diagnosis in Midlife: Study of Women's Health Across the Nation (SWAN)
Mitro, S. D., Waetjen, L. E., Lee, C., Wise, L. A., Zaritsky, E. F., Harlow, S. D., Khoudary, S. R. E., Santoro, N. F., Solomon, D. H., Thurston, R. C., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae625 · Cited by 14
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
